PTPIPetros Pharmaceuticals, Inc.

NAS · US · Healthcare · Drug Manufacturers - Specialty & Generic · petrospharma.com

0.0040USD+2.56%Mkt Cap: 169489 $P/E: 0.003d ago

Petros Pharmaceuticals, Inc., a healthcare technology company, focuses on developing and licensing proprietary software as a service (SaaS) platform and Software as a medical device web application designed to assist pha…

Industry Peers

Drug Manufacturers - Specialty & Generic

Screen all

MRK

MERCK Kommanditgesellschaft auf Aktien

$65.19BUSDP/E 23.7

TAK

Takeda Pharmaceutical Co. Ltd.

$58.06BUSD

HLN

Haleon plc American Depositary Shares (Each representing two Ordinary Shares)

$43.98BUSDP/E 20.4

TEVA

Teva Pharmaceutical Industries Limited

United Therapeutics Corporation

Swedish Orphan Biovitrum AB

Neurocrine Biosciences, Inc.

$15.51BUSDP/E 22.3

ELAN

Elanco Animal Health Incorporat

$11.98BUSD

RDY

Dr. Reddy's Laboratories Ltd

Hims & Hers Health, Inc.

$7.88BUSD

LNTH

Lantheus Holdings Inc

$6.53BUSDP/E 23.9

AMRX

Amneal Pharmaceuticals, Inc. Class A

Kiniksa Pharmaceuticals, Ltd.

$6.08BUSDP/E 79.8

Key Statistics

Company

Market Cap169.49K $

Enterprise Value-3.34M $

Revenue (TTM)—

Gross Profit0 $

Net Income (TTM)1.91M $

Revenue/Share—

Last Price0.0040 USD

Fiscal Year EndDec 2025

MR QuarterJun 2026

Employees3

CountryUS

SectorHealthcare

IndustryDrug Manufacturers - Specialty & Generic

ISIN—

Valuation

P/E (Trailing)0.00

P/E (Forward)-0.00

PEG—

EV/EBITDA—

EV/Revenue—

P/S—

P/B0.10

EPS (TTM)1.28

EPS (Forward)-1.09

52W Range

0.00206% of range0.0330

52W High0.0330 USD

52W Low0.0020 USD

Profitability

Gross Margin0.00%

Oper. Margin0.00%

EBITDA Margin0.00%

Profit Margin0.00%

ROE66.66%

ROA37.06%

Growth

Revenue Growth—

Earnings Growth—

Cash Flow & Leverage

Operating CF-6.73M $

CapEx (TTM)—

FCF Margin—

FCF Yield-1124.54%

Net Debt-3.49M $

Net Debt/EBITDA—

Balance Sheet

Debt/Equity—

Current Ratio1.25

Quick Ratio1.23

Book Value/Sh0.0420 USD

Cash/Share0.0820 USD

Dividends

Fwd Div Rate—

Trail. Div Rate0.0000 USD

Div. Yield—

5Y Avg Yield—

Payout Ratio0.00%

Ex-Div Date—

Pay Date—

Splits

Last Split1:25

Split DateMay 1, 2025

Analyst Consensus

Rating—

Target (Mean)—

Target Range—

# Analysts—

Ownership

Shares Out.42.37M

Float28.93M

Insiders24.08%

Institutions10.24%

Short Interest

Short Ratio0.2d

Short % Float25.07%

Short % Out.24.06%

Shares Short493.83K

Short (prev mo.)59.27K

Technical

SMA 500.0045 (-11.9%)

SMA 2000.0078 (-48.6%)

Beta—

S&P 52W Chg18.16%

Avg Vol (30d)93.51K

Avg Vol (10d)173.63K

Technical Indicators

RSI (14)54.4

MACD-0.0003

MACD Signal-0.0005

MACD Hist.+0.0002

BB Upper0.0044 USD

BB Middle0.0033 USD

BB Lower0.0023 USD

BB Width61.39%

ATR (14)0.0006 USD

Vol Ratio (20d)2.26x